Examkin

Question

Difficulty: EasyPediatric Respiratory Disorders

A 5-year-old boy arrives at the urgent care center with his mother because he has been struggling to breathe since early morning. His medical background is notable for atopic dermatitis and two prior episodes of respiratory distress requiring medical intervention in the past year. Over the preceding 48 hours, he developed severe nasal congestion and a dry, hacking cough. Today, his respiratory effort significantly worsened. His body temperature is 37.3°C (99.1°F), pulse is 125/min, and respirations are 36/min. Oxygen saturation is 92% on ambient air. Physical assessment demonstrates an anxious child in visible distress with prominent intercostal and subcostal retractions. Auscultation of the lungs reveals a prolonged expiratory phase accompanied by high-pitched, widespread expiratory wheezing. Which of the following is the most appropriate initial step in the management of this patient?

  1. A
    Administration of nebulized racemic epinephrine and systemic corticosteroids
  2. B
    Initiation of intravenous broad-spectrum antibiotic therapy
  3. Concurrent administration of an inhaled short-acting beta-agonist and systemic corticosteroidsAnswer
  4. D
    Routine observation, oral hydration, and clearance of nasal secretions
  5. E
    Immediate initiation of long-acting beta-agonist monotherapy

Answer

Concurrent administration of an inhaled short-acting beta-agonist and systemic corticosteroids
This patient's presentation of progressive respiratory distress, hypoxia, retractions, and diffuse expiratory wheezing in the setting of a viral prodrome is highly characteristic of an acute asthma exacerbation. His personal history of atopic dermatitis and recurrent wheezing further supports this diagnosis, representing the classic 'atopic march.' The standard of care for the initial management of a moderate-to-severe acute asthma exacerbation requires addressing both bronchospasm and airway inflammation simultaneously. Inhaled short-acting beta-agonists (e.g., albuterol) provide rapid bronchodilation, while systemic corticosteroids (e.g., oral dexamethasone or prednisone) are essential to mitigate the underlying inflammatory cascade, prevent early relapse, and reduce the need for hospitalization.

Step-by-Step Solution

1
Analyze the patient's demographic and clinical history.
5-year-old boy with a history of atopic dermatitis and recurrent respiratory distress episodes.
Identifying the atopic march (eczema progressing to reactive airways) and a pattern of recurrent wheezing strongly points to an underlying diagnosis of pediatric asthma.
2
Evaluate the current physical examination findings and vital signs.
Tachypnea, hypoxemia (92% on room air), intercostal retractions, and diffuse high-pitched expiratory wheezing.
These findings confirm a moderate-to-severe acute lower airway obstruction, consistent with an acute asthma exacerbation triggered by a recent viral upper respiratory infection.
3
Determine the most appropriate initial pharmacological intervention based on the diagnosis and severity.
Select short-acting beta-agonists (SABA) and systemic corticosteroids.
SABA provides rapid reversal of smooth muscle bronchospasm, while systemic corticosteroids address the underlying severe airway inflammation. Both are mandatory first-line treatments for this presentation.

Key Concept

The initial management of an acute asthma exacerbation involves rapid reversal of bronchospasm with inhaled short-acting beta-agonists and reduction of airway inflammation with systemic corticosteroids.
Rate this question

Topics

Pediatric Respiratory Disorders

More questions from this topic